AccutarBio Company
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Technology:
Artificial Intelligence, Biopharma, Biotechnology, Machine Learning
Industry:
AI, Early Drug Development
Headquarters:
Shanghai, Shanghai, China
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
3
Total Funding:
76613745
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-01-05
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership